Medplus Health Services Announces ₹130 Crore Share Buyback

Maximum Buyback Size: ₹130 crore.
Maximum Buyback Price: ₹750 per equity share.

Reader Takeaway: The open market buyback provides capital return to public investors while increasing their proportional stake in Medplus.

What just happened

Medplus Health Services Limited has received board approval to initiate a share buyback program via the open market through the stock exchange. The company plans to allocate up to ₹130 crore to repurchase fully paid-up equity shares with a face value of ₹2 each. The buyback is capped at a price of ₹750 per share.

Why this matters

This move serves as a mechanism to return capital to shareholders. Because the promoters and persons in control of the company are explicitly excluded from the buyback, the transaction will effectively increase the proportional ownership stake held by public shareholders. The company has committed to a minimum utilization of 75% of the total buyback amount, ensuring the program is executed with a significant capital commitment of at least ₹97.50 crore.

Buyback Mechanics

The buyback will be executed through the stock exchange mechanism in compliance with SEBI (Buy-Back of Securities) Regulations, 2018. A dedicated Buyback Committee has been formed to oversee the process, with Shrenik Soni appointed as the compliance officer. Nuvama Wealth Management Limited has been appointed to manage the execution of the program.

Financial Context

The allocation of ₹130 crore represents approximately 9.87% of the standalone and 6.61% of the consolidated aggregate of the company’s fully paid-up equity share capital and free reserves as of March 31, 2026. This allocation remains well within the statutory limit of 15% permitted by current regulations.

What to track next

Shareholders should look for subsequent public announcements regarding the specific start date, implementation timelines, and the duration of the open market acquisition window.